About 4-[4,4-dimethyl-3-[3-[4-(6-methyl-3-pyridinyl)phenoxy]propyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
4-[4,4-dimethyl-3-[3-[4-(6-methyl-3-pyridinyl)phenoxy]propyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile (PubChem CID 118182299) has the molecular formula C28H25F3N4O2S
and a molecular weight of 538.60 g/mol. Its IUPAC name is 4-[4,4-dimethyl-3-[3-[4-(6-methyl-3-pyridinyl)phenoxy]propyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile.
Molecular Properties
| Compound Name | 4-[4,4-dimethyl-3-[3-[4-(6-methyl-3-pyridinyl)phenoxy]propyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile |
| PubChem CID | 118182299 |
| Molecular Formula | C28H25F3N4O2S |
| Molecular Weight | 538.60 g/mol |
| Exact Mass | 538.17 |
| IUPAC Name | 4-[4,4-dimethyl-3-[3-[4-(6-methyl-3-pyridinyl)phenoxy]propyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile |
| SMILES | Cc1ccc(-c2ccc(OCCCN3C(=S)N(c4ccc(C#N)c(C(F)(F)F)c4)C(=O)C3(C)C)cc2)cn1 |
| InChI | InChI=1S/C28H25F3N4O2S/c1-18-5-6-21(17-33-18)19-8-11-23(12-9-19)37-14-4-13-34-26(38)35(25(36)27(34,2)3)22-10-7-20(16-32)24(15-22)28(29,30)31/h5-12,15,17H,4,13-14H2,1-3H3 |
| InChIKey | ICGLRQAZZYDKIT-UHFFFAOYSA-N |
| XLogP | 6.13 |
| TPSA | 69.46 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 538.60 |
| LogP ≤ 5 | 6.13 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'} |
|---|
Analyze 4-[4,4-dimethyl-3-[3-[4-(6-methyl-3-pyridinyl)phenoxy]propyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-[4,4-dimethyl-3-[3-[4-(6-methyl-3-pyridinyl)phenoxy]propyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile?
The IUPAC name of 4-[4,4-dimethyl-3-[3-[4-(6-methyl-3-pyridinyl)phenoxy]propyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile (CID 118182299) is 4-[4,4-dimethyl-3-[3-[4-(6-methyl-3-pyridinyl)phenoxy]propyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile.
What is the SMILES notation for 4-[4,4-dimethyl-3-[3-[4-(6-methyl-3-pyridinyl)phenoxy]propyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile?
The canonical SMILES for 4-[4,4-dimethyl-3-[3-[4-(6-methyl-3-pyridinyl)phenoxy]propyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile is Cc1ccc(-c2ccc(OCCCN3C(=S)N(c4ccc(C#N)c(C(F)(F)F)c4)C(=O)C3(C)C)cc2)cn1.
What is the InChIKey of 4-[4,4-dimethyl-3-[3-[4-(6-methyl-3-pyridinyl)phenoxy]propyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile?
The InChIKey is ICGLRQAZZYDKIT-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H25F3N4O2S/c1-18-5-6-21(17-33-18)19-8-11-23(12-9-19)37-14-4-13-34-26(38)35(25(36)27(34,2)3)22-10-7-20(16-32)24(15-22)28(29,30)31/h5-12,15,17H,4,13-14H2,1-3H3.
What are the key properties of 4-[4,4-dimethyl-3-[3-[4-(6-methyl-3-pyridinyl)phenoxy]propyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile?
4-[4,4-dimethyl-3-[3-[4-(6-methyl-3-pyridinyl)phenoxy]propyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile has a molecular weight of 538.60 g/mol, XLogP of 6.13, 7 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[4,4-dimethyl-3-[3-[4-(6-methyl-3-pyridinyl)phenoxy]propyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile is sourced from PubChem (CID 118182299), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).